Delivery Order SPE2DR25D7068-SPE2DR26F5BZ8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,632.00 to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Spikevax 2025-26 vaccine (12 years and up) in 0.5ml syringes. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of December 31, 2025. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,052.80 on December 11, 2025, for the supply of Spikevax 2025-26 vaccine for individuals 12 years and older in 0.5 mL syringes. The contract is firm fixed price with no set-aside designation and is scheduled for completion by January 5, 2026. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Spikevax 2025-26 vaccine (12 years and up) in 0.5 mL syringes, valued at $14,201.30. This is a firm fixed price delivery order with no set-aside designation, reflecting competitive procurement practices. The contract is scheduled for completion by December 1, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Spikevax 2024-25 vaccine (12 years and up) in 0.5ML syringes, with a ceiling value of $1,177.48 and completion date of September 22, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction reflecting the agency's procurement of influenza vaccines to support military healthcare operations. The order was placed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,431.78 on June 18, 2025, for the supply of Spikevax 2024-25 vaccine (12 years and older) in 0.5 mL syringes. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 11, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $16,480.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Spikevax 2025-26 vaccine (12 years and older) in 0.5 mL syringes. The contract, which is non-set-aside and competitively awarded, is scheduled for completion by December 9, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,052.80 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and up) in 0.5 mL syringes. This competitively awarded, firm fixed-price contract was executed on December 8, 2025, with an ultimate completion date of December 30, 2025. The pharmaceutical product will be supplied from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,579.20 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and up) in 0.5mL syringe format, with completion targeted for December 26, 2025. This competitively awarded, non-set-aside delivery order represents a firm fixed-price transaction executed on December 4, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract is a child order...
- The Defense Logistics Agency awarded a $2,096.74 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of SPIKEVAX 2025-26 (12 years and up) in 0.5ml syringes. This is a firm fixed price, non-set-aside contract with a completion date of October 20, 2025, to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under a larger indefinite delivery contract vehicle, enabling the pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,683.33 on December 10, 2025, for the supply of SPIKEVAX 2025-26 (12 years and up) vaccine in 0.5 mL syringes. The contract represents a firm fixed-price delivery order with an ultimate completion date of January 2, 2026, and was competitively awarded without set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal...
- SPE2DR25D7068Indefinite Delivery Contract
- SPE2DR25D7068-SPE2DR26F5BZ8Delivery Order
The Defense Logistics Agency awarded a $2,631.95 delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Spikevax 2025-26 vaccine (12 years and up) in 0.5ML syringes. This is a firm fixed-price, non-set-aside contract with performance completion scheduled for January 8, 2026, and work to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a discrete purchase under a larger contract vehicle supporting federal medical procurement needs. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's significant Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen is a major pharmaceutical distributor and critical federal vendor that supplies comprehensive medical products including vaccines, medications, and medical devices across multiple therapeutic categories to support military healthcare systems, the Defense Health Agency, and other government healthcare programs. The company's demonstrated capability to fulfill federal procurement requirements through open competition across a diverse product portfolio positions it as a primary supplier for the DLA's global pharmaceutical support mission.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 12/15/25 |